These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 17435103
21. Efficacy and safety of the combination imidacloprid 10 % / moxidectin 1.0 % spot-on (Advocate(®) spot-on for small cats and ferrets) in the treatment of ear mite infection (Otodectes cynotis) in ferrets. Le Sueur C, Bour S, Schaper R. Parasitol Res; 2011 Aug; 109 Suppl 1():S149-56. PubMed ID: 21739384 [Abstract] [Full Text] [Related]
22. Evaluation of the efficacy of an imidacloprid 10%/moxidectin 2.5% spot-on against Sarcoptes scabieivar canison dogs. Fourie LJ, Du Rand C, Heine J. Parasitol Res; 2003 Jul; 90 Suppl 3():S135-6. PubMed ID: 12928880 [No Abstract] [Full Text] [Related]
25. Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis. Beugnet F, Halos L, Larsen D, de Vos C. Parasite; 2016 Jul; 23():14. PubMed ID: 27012161 [Abstract] [Full Text] [Related]
26. Chemical Compatibility and Safety of Imidacloprid/Flumethrin Collar (Seresto®) Concomitantly Used with Imidacloprid/Moxidectin (Advocate®, Advantage® Multi) and Emodepside/Praziquantel (Profender®) Spot-on Formulations. Krüdewagen EM, Remer C, Deuster K, Schunack B, Wolken S, Crafford D, Fourie J, Stanneck D. Parasitol Res; 2015 Aug; 114 Suppl 1():S55-80. PubMed ID: 26152409 [Abstract] [Full Text] [Related]
27. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes. Paterson TE, Halliwell RE, Fields PJ, Louw ML, Ball G, Louw J, Pinckney R. Vet Parasitol; 2014 Oct 15; 205(3-4):687-96. PubMed ID: 25262617 [Abstract] [Full Text] [Related]
28. Efficacy of a spot-on formulation of pyriprole on dogs infested with Sarcoptes scabiei. Fourie JJ, Horak IG, de la Puente Redondo V. Vet Rec; 2010 Sep 18; 167(12):442-5. PubMed ID: 20852247 [Abstract] [Full Text] [Related]
33. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866). Willesen JL, Kristensen AT, Jensen AL, Heine J, Koch J. Vet Parasitol; 2007 Jul 20; 147(3-4):258-64. PubMed ID: 17544583 [Abstract] [Full Text] [Related]
35. What is your diagnosis? Juvenile-onset generalised demodicosis. Neuber AE. J Small Anim Pract; 2004 Nov 20; 45(11):537, 575-6. PubMed ID: 15553190 [No Abstract] [Full Text] [Related]
36. Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study. Becskei C, Cuppens O, Mahabir SP. Vet Dermatol; 2018 Apr 20; 29(2):100-e39. PubMed ID: 29392787 [Abstract] [Full Text] [Related]
38. Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate®, Advantage® Multi) in Comparison to an Untreated Control Group in the Treatment of Capillaria boehmi in Naturally Infected Dogs. Veronesi F, Di Cesare A, Braun G, Günther L, Morganti G, Rueca F, Petry G, Schaper R, Traversa D. Parasitol Res; 2017 Aug 20; 116(Suppl 1):65-74. PubMed ID: 28717949 [No Abstract] [Full Text] [Related]
39. Use of a 0.25 per cent fipronil pump spray formulation to treat canine cheyletiellosis. Chadwick AJ. J Small Anim Pract; 1997 Jun 20; 38(6):261-2. PubMed ID: 9200117 [Abstract] [Full Text] [Related]
40. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study. Becskei C, Cuppens O, Mahabir SP. Vet Dermatol; 2018 Jun 20; 29(3):203-e72. PubMed ID: 29423956 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]